Cargando…
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
Results from model tumour systems suggest that either increased levels of certain metalloproteases (MMPs) or decreased levels of their inhibitors correlate with metastatic potential. In this study, levels of two MMPs, i.e. MMP-8 and -9, and their inhibitor tissue inhibitor of metalloprotease type 1...
Autores principales: | Duffy, M. J., Blaser, J., Duggan, C., McDermott, E., O'Higgins, N., Fennelly, J. J., Tschesche, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033810/ https://www.ncbi.nlm.nih.gov/pubmed/7734294 |
Ejemplares similares
-
Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
por: Remacle, A. G., et al.
Publicado: (1998) -
Plasminogen activator inhibitor type 2 in breast cancer.
por: Duggan, C., et al.
Publicado: (1997) -
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
por: Duffy, Michael J, et al.
Publicado: (2000) -
Interleukin-17 and matrix metalloprotease-9 expression in the mycetoma granuloma
por: Siddig, Emmanuel Edwar, et al.
Publicado: (2019) -
Overexpression of the Ets-1 transcription factor in human breast cancer
por: Buggy, Y, et al.
Publicado: (2004)